Correlation Between Grifols SA and Eli Lilly

Can any of the company-specific risk be diversified away by investing in both Grifols SA and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grifols SA and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Grifols SA ADR and Eli Lilly and, you can compare the effects of market volatilities on Grifols SA and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grifols SA with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grifols SA and Eli Lilly.

Diversification Opportunities for Grifols SA and Eli Lilly

-0.29

Correlation Coefficient

Grifols SA  Eli Lilly

Very good diversification

The 3 months correlation between Grifols and Eli is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Grifols SA ADR and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Grifols SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grifols SA ADR are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Grifols SA i.e., Grifols SA and Eli Lilly go up and down completely randomly.

Pair Corralation between Grifols SA and Eli Lilly

Given the investment horizon of 90 days Grifols SA ADR is expected to generate 1.73 times more return on investment than Eli Lilly. However, Grifols SA is 1.73 times more volatile than Eli Lilly and. It trades about -0.11 of its potential returns per unit of risk. Eli Lilly and is currently generating about -0.24 per unit of risk. If you would invest  665.00  in Grifols SA ADR on January 27, 2024 and sell it today you would lose (38.00) from holding Grifols SA ADR or give up 5.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Grifols SA ADR  vs.  Eli Lilly and

Grifols SA ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Eli Lilly

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Grifols SA and Eli Lilly

The main advantage of trading using opposite Grifols SA and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grifols SA position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.

The idea behind Grifols SA ADR and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.